Now the medicine to cure obesity has arrived in India, diabetes will also be controlled, know how much it costs and who it is for
KalamTimes March 28, 2025 10:39 PM

Weight Loss Drug in India: Weight loss drug has now arrived in India as well. This drug named Maunjoro also controls diabetes. Let us know the price of this drug.

 

Highlights

  • Maunzaro launched in India for weight and diabetes control.
  • However, the price of the Maujaro will be very high at present.
  • 14 crore people in the country suffer from obesity and diabetes.

Weight Loss Drug in India: Weight loss drugs are already being used in Europe and America, but for the first time in India, it has been launched under the name Maanzaro. American multinational pharma company Eli Lilly has launched Maanzaro in the Indian market. It has already received approval from the Indian drug regulator. Novo Nordisk company's drug Vigovy is very popular abroad. Obesity and diabetes are both big challenges in India and many people are victims of both these diseases together. In such a situation, the arrival of Maanzaro can prove to be a new ray of hope for millions of people.

How much can be expected

Eli Lilly has kept its price in India at $50. That means the price of one 5 mg injection will be $50.67. If it is converted into rupees, it will be Rs 4375. At the same time, the price of one 2.5 mg injection will be $40.54 i.e. Rs 3500. If a person has to take this 5 mg medicine, then he will have to spend 16 thousand rupees every month. However, this price is also decided on the basis of insurance. Of course its price may be high but its demand is very high because in India people are increasingly suffering from obesity and diabetes. In such a situation, hardly anyone looks at the price.

How does Mounjaro work?

In the Indian Express report, Dr. Manisha Arora explains that Mounjaro mimics two hormones. It mimics glucagon-like peptide GLP-1 and gastric inhibitory polypeptidine GIP. Both these hormones regulate blood sugar, suppress appetite and slow down digestion. This makes the patient feel full. Mounjaro works on both hormones, while the weight loss drug Ozempic being sold abroad targets only GLP-1.

 

Who needs this medicine?

Any adult who has type 2 diabetes can take this medicine on the advice of the doctor. This medicine is also effective for those who are overweight. For those who have the problem of both obesity and diabetes, this medicine will work like a panacea. However, this medicine should be taken only on the advice of doctors. On the other hand, this medicine is not for pregnant women, type 1 diabetes patients, pancreatic cancer and thyroid cancer patients and patients with serious gastro diseases. It will cause harm.

© Copyright @2025 LIDEA. All Rights Reserved.